# Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea

> **NCT05881512** · NA · COMPLETED · sponsor: **Somnial Inc** · enrollment: 12 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- OSA

## Interventions

- **DEVICE:** Transcutaneous Upper Airway Stimulation Device

## Key facts

- **NCT ID:** NCT05881512
- **Lead sponsor:** Somnial Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-12
- **Primary completion:** 2022-09-18
- **Final completion:** 2023-02-22
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05881512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05881512, "Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05881512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*